Skip to Main Content

Author Details

Audrey Dang
Tulane University School of Medicine
2018
13
6
PMIDPaper TitleJournal TitlePublished Year
37141981High Recurrence for HPV-Positive Oropharyngeal Cancer With Neoadjuvant Radiation Therapy to Gross Disease Plus Immunotherapy: Analysis From a Prospective Phase Ib/II Clinical Trial.Int J Radiat Oncol Biol Phys2023
34990726Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiation.Radiother Oncol2022
35717044Embracing the Practical Aspects of Theranostics With Prostate-Specific Membrane Antigen-Targeted Lutetium-177.Pract Radiat Oncol2022
33035622Dose-response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control.Radiother Oncol2021
32509582Development and Validation of a Comprehensive Multivariate Dosimetric Model for Predicting Late Genitourinary Toxicity Following Prostate Cancer Stereotactic Body Radiotherapy.Front Oncol2020
32663537Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients.Radiother Oncol2020
30735235Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer.JAMA Netw Open2019
32529134Gantry-Mounted Linear Accelerator-Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer.Adv Radiat Oncol2019
31276777Multi-Institutional Analysis of Prostate-Specific Antigen Kinetics After Stereotactic Body Radiation Therapy.Int J Radiat Oncol Biol Phys2019
29507483Assessing post-radiotherapy handover notes from a family physician perspective.Curr Oncol2018
29719439Factors affecting radiotherapy prescribing patterns in the post-mastectomy setting.Curr Oncol2018
30050792Image-guided radiotherapy for prostate cancer.Transl Androl Urol2018
29805937Stereotactic Magnetic Resonance-guided Online Adaptive Radiotherapy for Oligometastatic Breast Cancer: A Case Report.Cureus2018
  • 1 - 13 of 13

Recommended Authors

Robert T Dess
University of Michigan ann arbor
Career Start Year 2016
Number of shared co-authors 29
Andrew Warner
Western University and London Regional Cancer Program
Career Start Year 2013
Number of shared co-authors 4
Rachel M Glicksman
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 24
Kiri A Sandler
Oregon Health and Science University
Career Start Year 2012
Number of shared co-authors 22
Darlene Veruttipong
Stanford University
Career Start Year 2012
Number of shared co-authors 7
Stephen Greco
Johns Hopkins University School of Medicine
Career Start Year 2012
Number of shared co-authors 25
Xin Pei
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 3
Alan Dal Pra
University of Miami Miller School of Medicine
Career Start Year 2010
Number of shared co-authors 8
Suneil Jain
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 3
Bradley J Stish
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 25
Rahul D Tendulkar
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 2006
Number of shared co-authors 21
Bridget F Koontz
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 11
Nicholas van As
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Career Start Year 2005
Number of shared co-authors 3
Himanshu Nagar
New York-Presbyterian Hospital, Weill Cornell Medical Center
Career Start Year 2005
Number of shared co-authors 12
Neil B Desai
University of Texas Southwestern Medical Center
Career Start Year 2004
Number of shared co-authors 12
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Career Start Year 2004
Number of shared co-authors 24
Piet Ost
Ghent University, GZA Ziekenhuizen
Career Start Year 2002
Number of shared co-authors 14
Andrew K Lee
Texas Center for Proton Therapy
Career Start Year 2001
Number of shared co-authors 0
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 2
Daniel J Krauss
William Beaumont School of Medicine
Career Start Year 1999
Number of shared co-authors 23
Danny Y Song
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 25
Robert B Den
Thomas Jefferson University Hospital
Career Start Year 1999
Number of shared co-authors 15
Gert De Meerleer
University Hospitals Leuven
Career Start Year 1997
Number of shared co-authors 8
Eric Vigneault
Centre Hospitalier Universitaire de Quebec
Career Start Year 1997
Number of shared co-authors 8
Vincent Khoo
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Career Start Year 1996
Number of shared co-authors 4
Jonathan D Tward
Huntsman Cancer Institute, University of Utah
Career Start Year 1994
Number of shared co-authors 23
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year 1994
Number of shared co-authors 3
Jeff M Michalski
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 26
Mack Roach
University of California San Francisco
Career Start Year 1983
Number of shared co-authors 21
Howard M Sandler
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 1976
Number of shared co-authors 27

Collaborators

Amar U Kishan
University of California los angeles
Co-authored papers 9
Michael L Steinberg
University of California los angeles
Co-authored papers 9
Patrick A Kupelian
university of california los angeles Medical Center
Co-authored papers 7
Minsong Cao
University of California Los Angeles
Co-authored papers 7
Nicholas G Nickols
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 6
Constantine A Mantz
University of Chicago
Co-authored papers 5
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 4
Fang-I Chu
David Geffen School of Medicine, University of California los angeles
Co-authored papers 4
Naomi Y Jiang
University of California los angeles
Co-authored papers 4
Christopher R King
University of California los angeles
Co-authored papers 4
Nima Aghdam
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers 4
Sean P Collins
Vanderbilt University School of Medicine
Co-authored papers 4
Rebecca Levin-Epstein
University of California los angeles
Co-authored papers 4
Hilary P Bagshaw
Stanford University
Co-authored papers 4
David Shabsovich
university of california los angeles Medical Center
Co-authored papers 4
Ye Yuan
Southwest Hospital, Army Medical University
Co-authored papers 4
Mark K Buyyounouski
Stanford University
Co-authored papers 4
Aleksandra Napieralska
MSC National Research Institute of Oncology Gliwice Branch
Co-authored papers 3
Alan W Katz
University of Rochester
Co-authored papers 3
Leszek Miszczyk
MSC National Research Institute of Oncology Gliwice Branch
Co-authored papers 3
Agnieszka Namys??-Kaletka
Maria Sklodowska-Curie National Research and Institute of Oncology
Co-authored papers 3
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Co-authored papers 3
Joanne B Weidhaas
University of California-Los Angeles
Co-authored papers 3
Simeng Suy
MedStar Georgetown University Hospital
Co-authored papers 3
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Co-authored papers 2
Nzhde Agazaryan
University of California los angeles
Co-authored papers 2
Daniel A Low
University of California los angeles
Co-authored papers 2
Donald B Fuller
Division of Genesis Healthcare Partners Inc., CyberKnife Centers of San Diego Inc.
Co-authored papers 2
William C Jackson
University of Michigan ann arbor
Co-authored papers 2
Brandon A Mahal
Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine
Co-authored papers 2
Release 1.2